Why the Obesity Drug Revolution Is a Work in Progress
1 week ago

Why the Obesity Drug Revolution Is a Work in Progress

Bloomberg  

A new class of weight-loss drugs known as GLP-1s are proving to be game changers for people with obesity. They’re also minting billions for pharmaceutical companies, especially the companies that developed them, Eli Lilly & Co. and Novo Nordisk A/S. It also remains unclear whether pharma companies can actually deliver on the promise of even better weight-loss drugs — part of the premise behind their high stock prices. Another unknown variable is Robert F. Kennedy Jr., President-elect Donald Trump ’s nominee to head the US Department of Health and Human Services, who has expressed reservations about the pharma industry — and its new wonder drug category. The two main GLP-1 obesity drugs currently on the market are Novo’s Wegovy and Lilly’s Zepbound, which are both taken as weekly injections.

Drug  weightloss  work  pharma  progress  zepbound  obesity  lillys  drugs  diabetes  revolution  wegovy  companies  drug

History of this topic

It’s getting harder to claim success with weight reduction drugs
1 week, 1 day ago

It’s getting harder to claim success with weight reduction drugs

Live Mint  

In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s stock price to fall by as much as 29%. CagriSema is a combination of the GLP-1 agonist semaglutide, the ingredient found in Novo’s Ozempic and Wegovy, and cagrilintide, …

Junk food companies 'freaking out' as people on weight-loss meds eat better: columnist
1 week, 1 day ago

Junk food companies 'freaking out' as people on weight-loss meds eat better: columnist

Raw Story  

Junk food companies are starting to get nervous over how many Americans use GLP-1 medications to lose weight. Washington Post columnist Catherine Rampell walked through shocking details of the economic impact of drugs like Wegovy and Ozempic cited in a new study by Cornell University and Numerator. Meanwhile, the Danish pharmaceutical company Novo Nordisk, which makes Ozempic and Wegovy, made …

FDA declares the shortage of obesity drug Zepbound has ended. The results are complicated
1 week, 5 days ago

FDA declares the shortage of obesity drug Zepbound has ended. The results are complicated

NPR  

FDA declares the shortage of obesity drug Zepbound has ended. SCOTT SIMON, HOST: The drug Zepbound might not have the same name recognition as Ozempic, but it's another in the class to treat obesity and Type 2 diabetes. The compounders said there was no way the shortage could be over, because many patients still couldn't fill their name-brand prescriptions, and …

Weight-loss drugs: A game changer for India’s top pharma companies
2 weeks, 3 days ago

Weight-loss drugs: A game changer for India’s top pharma companies

Live Mint  

Over 650 million adults globally suffer from obesity, and this number is only expected to rise. India’s rising players in the GLP-1 market Indian pharmaceutical giants like Sun Pharma, Cipla, Dr. Reddy’s, Natco Pharma, and Lupin are in a fierce race to bring obesity drugs to the Indian market. Cipla: Entering the market with generics Cipla, one of India’s most …

FDA approves Zepbound: First prescription medication for obstructive sleep apnea in adults
2 weeks, 5 days ago

FDA approves Zepbound: First prescription medication for obstructive sleep apnea in adults

India Today  

The US Food and Drug Administration has approved the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea : the weight-loss drug Zepbound. Zepbound may help adults with moderate-to-severe obstructive sleep apnea and obesity improve their sleep disorder. “This is a major step forward for patients with obstructive sleep apnea,” Dr. Sally Seymour, director of the FDA’s Division of …

Novo Nordisk’s share plunges 19.5% post release of weight loss drug CagriSema’s trial results
2 weeks, 6 days ago

Novo Nordisk’s share plunges 19.5% post release of weight loss drug CagriSema’s trial results

Live Mint  

The experimental next-generation obesity drug CagriSema helped overweight patients cut their weight by 22.7 percent in a late-stage trial, Reuters quoted Novo Nordisk as saying on Friday, adding the results were 25 percent they had expected. The new findings from the drug candidate deals a blow to the Danish drugmaker's ambitions for a successor to its popular Wegovy more powerful …

FDA says knockoff versions of Lilly obesity drug must come off the market
2 weeks, 6 days ago

FDA says knockoff versions of Lilly obesity drug must come off the market

Associated Press  

WASHINGTON — Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal decision issued Thursday. With demand for GLP-1 drugs booming, compounding pharmacies and telehealth companies like Hims and Ro have jumped into the market, selling cheaper versions online. …

Ozempic-like weight loss drugs to power OneSource as global demand soars
3 weeks, 6 days ago

Ozempic-like weight loss drugs to power OneSource as global demand soars

Live Mint  

Ozempic- and Wegovy-like drugs used to treat diabetes and obesity, will drive significant growth for OneSource Specialty Pharma Ltd, CEO and MD Neeraj Sharma said. Arun Kumar-led Strides Pharma Science, which has a market cap of ₹6,507 crore, announced the creation of OneSource Specialty Pharma, a specialty pharma pure-play CDMO player in September 2023—integrating Stelis Biopharma Ltd, Strides' Oral Technologies …

Consultations for obesity drug prescriptions are way up over 2023, survey finds
4 weeks ago

Consultations for obesity drug prescriptions are way up over 2023, survey finds

NPR  

Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. SYDNEY LUPKIN, BYLINE: Doctor Sarah Nosal, a family physician in the South Bronx, New York, says a lot more of her patients have come in asking about …

Doctors weigh societal costs of using drugs to treat obesity crisis
1 month ago

Doctors weigh societal costs of using drugs to treat obesity crisis

ABC  

It could be one of the most transformative medical advancements since the contraceptive pill: an injection of a peptide that mimics a hormone to suppress appetite. Yet beyond the controversies over side effects — nausea, headaches and even pancreatitis — these drugs mark a pivotal moment in addressing one of the world's most pressing health crises. A national report — …

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy
1 month ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today  

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
1 month ago

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Zepbound tops Wegovy for weight loss in Eli Lilly study
1 month ago

Zepbound tops Wegovy for weight loss in Eli Lilly study

Associated Press  

Share Share Copy Link copied Email Facebook X Reddit LinkedIn Pinterest Flipboard Print Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% …

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study
1 month ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint  

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial
1 month ago

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A rival drug company is celebrating results claiming its drug helps …

Eli Lilly and Novo Nordisk’s obesity moat just got stronger
1 month, 1 week ago

Eli Lilly and Novo Nordisk’s obesity moat just got stronger

Live Mint  

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. Not only did MariTide fail to outperform Lilly’s Zepbound, but both Lilly and Novo also have next-generation medications under development, with promising data showing even more impressive weight loss results. “A 20% weight loss would have been best-in-class if …

RFK Jr. Could Tank Biden's Ozempic Decision
1 month, 1 week ago

RFK Jr. Could Tank Biden's Ozempic Decision

Huff Post  

LOADING ERROR LOADING The prospect of Robert F. Kennedy Jr. presiding over the Department of Health and Human Services has sparked a lot of conversation about vaccines. The country’s national health system still covers and supports use of the new anti-obesity drugs, though guidelines urge providers and patients to try cheaper alternatives first. The group is among those that have …

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision
1 month, 1 week ago

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. The rule, unveiled on Tuesday by the Health …

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Trending News
1 month, 1 week ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Associated Press  

WASHINGTON — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound …

Study finds yet another use for popular diabetes and obesity drugs
1 month, 2 weeks ago

Study finds yet another use for popular diabetes and obesity drugs

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Called GLP-1 receptor agonists, the drugs mimic the action of a hormone called glucagon-like peptide …

What happens when Ozempic and Wegovy don’t work?
1 month, 2 weeks ago

What happens when Ozempic and Wegovy don’t work?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

As many as 1 in 5 people won’t lose weight with GLP-1 drugs, experts say
1 month, 2 weeks ago

As many as 1 in 5 people won’t lose weight with GLP-1 drugs, experts say

Associated Press  

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many …

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
1 month, 2 weeks ago

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Salon  

Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of …

Why Is There So Much Off-Brand Oral Ozempic for Sale Online?
1 month, 2 weeks ago

Why Is There So Much Off-Brand Oral Ozempic for Sale Online?

Wired  

Since they debuted, injectable GLP-1 drugs like Ozempic have been in high demand. It’s an appealing prospect—especially since these drugs are offered at a fraction of the price of their name-brand counterparts and are often shipped overnight after a prospective patient fills out a quick online questionnaire. “As a pharmacist, I can appreciate the excitement in the rise in oral …

Drugmakers and pharmacists battle over who gets to make obesity drugs
1 month, 2 weeks ago

Drugmakers and pharmacists battle over who gets to make obesity drugs

NPR  

Drugmakers and pharmacists battle over who gets to make obesity drugs toggle caption James Manning/PA Images/Getty Images Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high demand that the drugmakers have had a hard time keeping up. "Everybody knows that… injections are going to come off the shortage list eventually and patients need to …

Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?
1 month, 3 weeks ago

Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?

Live Mint  

Pharmaceutical companies are typically rewarded for their innovation with years of market exclusivity before cheaper generics enter the scene. That window for mass drug compounding, however, could start to close if the FDA upholds its recent determination that tirzepatide, the active ingredient in Eli Lilly’s Zepbound and Mounjaro, is no longer in short supply. If the FDA moves to restrict …

Weight-loss drug Wegovy launched in China
1 month, 3 weeks ago

Weight-loss drug Wegovy launched in China

CNN  

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Strong sales there and in the …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
1 month, 3 weeks ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

Blockbuster weight loss drugs are revealing what we still don’t understand about obesity
1 month, 3 weeks ago

Blockbuster weight loss drugs are revealing what we still don’t understand about obesity

CNN  

Editor’s note: Watch “Dr. While filming my new documentary about the drugs, it became clear that many people have at least considered taking GLP-1 medications, drawn to the possibility of steadier blood sugar, better heart health and especially weight loss. Although it wasn’t ultimately beneficial for ulcers, he told me, it was through a series of serendipitous discoveries that they …

Blockbuster weight loss drugs are revealing what we still don’t understand about obesity
1 month, 3 weeks ago

Blockbuster weight loss drugs are revealing what we still don’t understand about obesity

CNN  

Editor’s note: Watch “Dr. While filming my new documentary about the drugs, it became clear that many people have at least considered taking GLP-1 medications, drawn to the possibility of steadier blood sugar, better heart health and especially weight loss. Although it wasn’t ultimately beneficial for ulcers, he told me, it was through a series of serendipitous discoveries that they …

Truth about weight-loss jabs: Doctors reveal everyday habits which raise your risk of deadly side effects, why Mounjaro is riskier than Ozempic and the little-known sign of dangerous complications tha
1 month, 3 weeks ago

Truth about weight-loss jabs: Doctors reveal everyday habits which raise your risk of deadly side effects, why Mounjaro is riskier than Ozempic and the little-known sign of dangerous complications tha

Daily Mail  

It was the tragic news that doctors feared would come at some point. ‘So it’s important that anyone considering GLP-1 injections cuts back on these habits.’ THINK CAREFULLY BEFORE BUYING ONLINE Buying GLP-1 drugs from online pharmacies could increase the risk of life-threatening complications. ‘The risk is that patients who want to start this medication might report they are heavier …

Dr. Reddy’s to expand GLP-1 portfolio with focus on obesity and diabetes drug markets
2 months ago

Dr. Reddy’s to expand GLP-1 portfolio with focus on obesity and diabetes drug markets

Live Mint  

Mumbai: Dr. Reddy’s Laboratories Ltd aims to have about 15 GLP-1 drugs, used to treat obesity and diabetes, in its portfolio with various timelines, the pharma major’s chief executive officer Erez Israeli said after the company announced its September quarter results on Tuesday. With Danish company Novo Nordisk’s patent on semaglutide, a GLP-1 agonist used in popular brands Ozempic and …

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares
2 months ago

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares

Live Mint  

-- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field. Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could be a reality soon: People who took 100-milligram doses …

Big Pharma’s obesity bonanza faces new tests
2 months ago

Big Pharma’s obesity bonanza faces new tests

Live Mint  

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
2 months, 1 week ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

The Crackdown on Compounded GLP-1 Meds Has Begun
2 months, 4 weeks ago

The Crackdown on Compounded GLP-1 Meds Has Begun

Wired  

Eli Lilly has sent cease-and-desist letters to hundreds of compounding pharmacies, telehealth companies, and medical spas making and selling “compounded” versions of tirzepatide. Eli Lilly specifically accused this oral tirzepatide seller of “experimenting” on its customers, noting that the US Food and Drug Administration has not approved any oral tirzepatide medications. Eli Lilly also targeted at least one weight-loss clinic …

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?
3 months ago

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The United …

What It’s Really Like to Take Ozempic
3 months, 1 week ago

What It’s Really Like to Take Ozempic

Slate  

GLP-1 drugs like Ozempic, WeGovy, Mounjaro and others revolutionized weight loss and chronic weight management. Over the course of a year, Johann dived into the research and history behind GLP-1 drugs and how they became the latest and most effective way to lose weight. His latest book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs …

Column: The Ozempic revolution in weight-loss drugs exposes the weakest links in our healthcare system — drug pricing and insurance
4 months, 1 week ago

Column: The Ozempic revolution in weight-loss drugs exposes the weakest links in our healthcare system — drug pricing and insurance

LA Times  

The diabetes and weight-loss drug Ozempic. This limits the length of time that health gains can be internalized as reduced claims.’ — David Anderson, University of South Carolina health policy expert Yet millions of Americans are unable to access these drugs, thanks to the two big, interrelated flaws in our healthcare system: unrestrained pricing by drug companies and the economics …

Eli Lilly is gaining on Novo Nordisk in the obesity race
4 months, 4 weeks ago

Eli Lilly is gaining on Novo Nordisk in the obesity race

Live Mint  

The two companies’ divergent earnings reports this week showed that Indianapolis-based Lilly is moving faster than its Denmark-headquartered counterpart in the race to win the GLP-1 war. Less than a year after approval, Eli Lilly’s weekly prescription volume of Zepbound is about where Novo was with Wegovy volume more than two years in, according to JPMorgan data. And while all …

Wegovy: Ozempic sister drug to be sold in Australia within days
5 months, 1 week ago

Wegovy: Ozempic sister drug to be sold in Australia within days

Daily Mail  

A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within days. Like Ozempic, the drug is administered through a once-weekly pen, however it contains a higher amount of the active ingredient and is used to manage chronic weight conditions, whereas Ozempic is only approved to manage type 2 diabetes. In May the Australian government …

Rivals emerge to Ozempic and Zepbound—but with a lag
5 months, 2 weeks ago

Rivals emerge to Ozempic and Zepbound—but with a lag

Live Mint  

The two dominant players in the obesity market will eventually make way for a few more competitors. On Wednesday, Roche’s stock gained 5.6%, adding roughly $14 billion to its market value, after it reported that Carmot’s once-daily pill helped patients lose 7.3% of their body weight at the four-week mark. While the data was from an early-stage study, it was …

It’s survival of the fittest for brands trying to get in on the Ozempic weight-loss industry
5 months, 3 weeks ago

It’s survival of the fittest for brands trying to get in on the Ozempic weight-loss industry

LA Times  

Before he began taking Mounjaro last summer, Nick Lovell was the weight-loss economy’s ideal customer. — Dr. Gary Foster, chief scientific officer at WeightWatchers Atkins, a WeightWatchers rival, also wants a bite of the lucrative market and has adopted similar language: We’re “your ally in a new era of weight loss,” the low-carb diet program says on a dedicated GLP-1 …

Wegovy weight-loss drug OK'd in China
6 months, 2 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

Wegovy weight-loss drug OK'd in China
6 months, 2 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and …

New weight loss drugs are on the way — and the health benefits are even more promising
6 months, 2 weeks ago

New weight loss drugs are on the way — and the health benefits are even more promising

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pharmaceutical companies are racing to develop new weight loss drugs following …

Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?
7 months, 1 week ago

Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?

LA Times  

Injectable weight-loss drugs can prevent serious health problems, which makes them extremely valuable. The financial impact on Medicare is tempered by a 2003 federal law that prevents the government health insurance program from covering weight-loss medications.The drugs can be added to formularies if prescribed for another “medically accepted indication,” such as to treat type 2 diabetes or reduce heart risk, …

Use of Wegovy and other weight-loss drugs soars among kids and young adults
7 months, 2 weeks ago

Use of Wegovy and other weight-loss drugs soars among kids and young adults

Associated Press  

At 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and was embarrassed to speak to people at his restaurant job. “I had given up hope.” But last year, the weight-loss drug Wegovy helped him shed 110 pounds in nine months, making the rural Tennessee teen part of a surge of adolescents …

World’s biggest food company launches fast food meals for Wegovy and Ozempic users
7 months, 2 weeks ago

World’s biggest food company launches fast food meals for Wegovy and Ozempic users

The Independent  

Sign up to IndyEat's free newsletter for weekly recipes, foodie features and cookbook releases Get our food and drink newsletter for free Get our food and drink newsletter for free SIGN UP I would like to be emailed about offers, events and updates from The Independent. The world’s biggest food company said it developed the new products with more protein, …

Discover Related